“This pandemic is changing the way research will be conducted” – Karri Venn, President, Research
COVID-19 has created a situation that has pushed both public and private research networks to “challenge the status quo” when it comes to conducting research. This week, Clinical Trials Ontario interviewed President, Research Karri Venn about LMC Manna Research’s response and action during the COVID-19 pandemic.
“This pandemic has afforded the entire research ecosystem an opportunity to challenge the status quo – we were quick to pivot and adjust our operations overnight.” – Karri Venn, President, Research
With LMC Manna’s history working on vaccines, including past research during the H1N1 pandemic, we are hoping to make connections, and continue to collaborate with other clinical research sites looking to conduct COVID-19 trials. As of now, we are hoping to have vaccine trials up and running in Ontario by July 2020.
Beyond vaccines, LMC Manna Research is also looking to study treatments for mild cases of COVID-19 and prophylaxis treatment for high risk/exposure candidates.
To read the full article, click here.
If you are interested to learn more about how you can participate in clinical trials for current and future COVID-19 treatment developments, please contact us at firstname.lastname@example.org or by sending us a message below.
Clinical Trials Ontario is a leading organization in the clinical trials community dedicated to strengthening, promoting and capitalizing on Ontario’s competitive advantages for conducting high-quality clinical trials. They work collaboratively with industry, research institutes, patients and the public and other health innovation organizations to improve the clinical trials environment and attract investment to the province, while supporting the highest ethical and quality standards.